PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France. thierry.conrozier@hnfc.fr.\', \'Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.\', \'Department of Biology, Nord Franche-Comté Hospital, Belfort, France.\', \'Department of Infectious Diseases, Nord Franche-Comté Hospital, Belfort, France.\', \'Intensive Care Unit, Nord Franche-Comté Hospital, Belfort, France.\', \'Pharmacy, Nord Franche-Comté Hospital, Belfort, France.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • Clinical and experimental rheumatology
is ?:pmid of
?:pmid
?:pmid
  • 32573419
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 85
is ?:relation_isRelatedTo_publication of
?:title
  • Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32573419>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32573419>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all